A study of ciclesonide nasal spray in patients 18 years and older with seasonal allergic rhinitis (BY9010/M1-413)

Inclusion Criteria

• Main Inclusion Criteria:
• - Written informed consent
• - General good health
• - History of SAR to short ragweed pollen for 2 years immediately preceding the study
• - Demonstrated sensitivity to short ragweed known to induce SAR through a standard skin prick test
• Main Exclusion Criteria:
• - Clinically significant physical finding of nasal anatomical deformities causing greater than 50% obstruction, including but not limited to nasal polyps, septal defects, respiratory tract malformations, nasal trauma or surgery
• - Known hypersensitivity to any corticosteroid
• - History of a respiratory infection or disorder including but not limited to bronchitis, pneumonia, chronic sinusitis, influenza or SARS (severe acute respiratory syndrome) within 14 days preceding the Screening Visit
• - History of alcohol or drug abuse within 2 years preceding the Screening Visit
• - Active asthma requiring treatment of inhaled or systemic corticosteroids and/or routine use of beta-agonists or any controller drugs
• - Use of antibiotic therapy for acute conditions within 14 days preceding the Screening Visit
• - Exposure to systemic corticosteroids for any indication, chronic or intermittent within 60 days preceding the Screening Visit